Definitive Contract 75N91018C00022
Award Date
9/24/18
Potential Completion Date
11/23/19
Potential Value
$225K
Federal Agency
National Cancer Institute
Awardee
Klesis, LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27705, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
12
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $399,987 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to Care Progress LLC, a small business limited liability company. The contract supports the development of cancer clinical trials recruitment and retention tools for participant engagement, as described in the original SBIR solicitation. The solicitation sought proposals for SBIR Phase I and Phase II contracts to conduct...
<p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $1,416,758.40 Cost Plus Fixed Fee contract to Sensopath Technologies, Inc., a Woman Owned Small Business, for a Small Business Innovation Research (SBIR) Program Phase II action. The contract, which has a total small business set aside, was awarded on September 28, 2012 with an ultimate completion date of May 22, 2015. The contract delivers research and development services under the SBIR program.</p>
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), awarded a $453,123 Small Business Innovation Research (SBIR) Phase I contract to Pistevo Decision LLC, a minority-owned small business, to develop an integrated multi-level decision support platform to address patient-centered and evidence-based social determinants of health among cancer patients. This Phase I contract is part of a two-year $2 million SBIR Phase II award granted to Pistevo in September 2023....
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a $224,759 Firm Fixed Price contract to Litmus Health, Inc., a small business, to develop an extensible and scalable platform for data integration from wearable sensors to generate novel analytics for cancer patients. This award is associated with the NIH/Centers for Disease Control and Prevention (CDC) Small Business Innovation Research (SBIR) Program Solicitation PHS...
This is a $399,992 firm fixed price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Xanthoshealth, Inc., a small business concern, to develop "Software to Address Social Determinants of Health in Oncology Practices" under the NCI's SBIR program. The original solicitation sought proposals for innovative research across various biomedical and public health topics, including digital health tools, to contribute towards the NCI and Centers for Disease Control and...
This Small Business Innovation Research (SBIR) Phase I contract, valued at $399,674, was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Inso Biosciences Inc., a small biotechnology startup. The contract supports the research and development of advanced sample processing platforms for downstream single-cell multi-omic analysis. This work aligns with the NIH and Centers for Disease Control and Prevention (CDC) mission to develop medical...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services' (HHS) National Institutes of Health (NIH) National Cancer Institute to Carevive Systems Inc., a woman-owned small business. The contract, valued at $1,725,000.00, is for the development of "Symptom Management and Intervention Roadmaps (STAIRS) (MOONSHOT)" to contribute toward meeting the program objectives of the NIH and Centers for Disease Control and Prevention...
This is a $225,000.00 Firm Fixed Price definitive contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Cognitive Medical Systems, Inc., a Service-Disabled Veteran-Owned Small Business. The contract is for "Bridging the Guideline Implementation Gap: Clinical Decision Support to Improve Cancer Symptom Management (MOONSHOT)." The contract was set aside for Small Businesses and was issued under the Small Business...
This SBIR Phase I contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Zymeron Corporation, a Minority Owned Small Business. The $349,790 Firm Fixed Price contract supports research and development of "Targeted and Sustained Release Microparticles for Colon Cancer Chemoprevention." This work is part of the NIH/CDC SBIR Program, which aims to stimulate technological...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $398,711 firm fixed price definitive contract to GMG Arcdata LLC. The contract is for a Phase I Small Business Innovation Research project under Solicitation A SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) FOR SMALL BUSINESS INNOVATION RESEARCH (SBIR) CONTRACT PROPOSALS. Specifically, GMG Arcdata will develop a...